Clinical trial
Randomized Control Study to Assess the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control vs Routine Medication Therapy in Patients With Recent Stroke: SAVE STROKE Phase II Study
NCT06783868 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Control Study to Assess the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control vs Routine Medication Therapy in Patients With Recent Stroke: SAVE STROKE Phase II Study
- Lead sponsor
- Kansas City Heart Rhythm Research Foundation
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2025
- Completion date
- June 30, 2027
- Enrollment
- 100 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.